PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
59.13%
Net income growth above 1.5x META's 10.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
17.35%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
109.00%
Slight usage while META is negative at -271.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
109.00%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-46.40%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
25.27%
Operating cash flow growth above 1.5x META's 6.39%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-40.32%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-215.58%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-70.66%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
108.81%
At 50-75% of META's 198.35%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
-100.00%
Both yoy lines negative, with META at -645.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
19.57%
We have mild expansions while META is negative at -29.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-16.59%
Negative yoy issuance while META is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.